Multisystem failure due to three coexisting autoimmune diseases

Internal Medicine

Volumn 48, Issue 10, 2009, Pages 837-842

  Pillai, Arvind ^a   Gautam, Manish ^a   Williamson, Helen ^a   Martlew, Vanessa ^a   Nash, John ^a   Thachil, Jecko ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Haemophilia; Myelofibrosis; Systemic lupus erythematosis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; BLOOD CLOTTING FACTOR 8; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; GAMMA GLUTAMYLTRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TEICOPLANIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACQUIRED HEMOPHILIA; ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; ASTHENIA; AUTOIMMUNE HEMOPHILIA; AUTOIMMUNE MYELOFIBROSIS; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DEEP VEIN THROMBOSIS; DRUG DOSE TITRATION; DYSPNEA; ECHOCARDIOGRAPHY; ECHOGRAPHY; EDEMA; FATTY LIVER; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERAL CONDITION DETERIORATION; HEMATOMA; HEMODIALYSIS; HEMOPHILIA; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; LETHARGY; LIVER BIOPSY; MYELOFIBROSIS; NEUTROPHILIA; PANCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYSEROSITIS; PROTEIN URINE LEVEL; PROTHROMBIN TIME; RESPIRATORY FAILURE; RETICULOCYTE COUNT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ADULT; AUTOIMMUNE DISEASES; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE ORGAN FAILURE; PANCYTOPENIA; PRIMARY MYELOFIBROSIS; SEROSITIS;

EID: 67649998933     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1957     Document Type: Article

References (22)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.
2. Beyan E, Beyan C, Turan M. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 12: 257-261, 2007.
3. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis. A steroid responsive cause of bone marrow fibrosis associated with systemic lupus erythematous. Medicine (Baltimore) 73: 145-152, 1994.
4. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 45: 200-203, 1981.
5. Daly HM, Scott GL. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 36: 1219-1222, 1983.
6. Smith RE, Chelmowski MK, Szabo EJ. Myelofibrosis: a review of clinical and pathologic features and treatment. Crit Rev Oncol Hematol 10: 305-314, 1990.
7. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis. A steroid responsive cause of bone marrow fibrosis associated with systemic lupus erythematous. Medicine (Baltimore) 73: 145-152, 1994.
8. Pereira RM, Velloso ER, Menezes Y, Gualandro S, Vassalo J, Yoshinari NH. Bone marrow findings in systemic lupus erythematosus with peripheral cytopenias. Clin Rheumatol 17: 219-222, 1998.
9. Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK. Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome. Am J Hematol 72: 8-12, 2003.
10. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139: 351-362, 2007.
11. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 82: 864-873, 2007.
12. Ishikawa T, Tsukamoto N, Suto M, et al. Acquired hemophilia A in a patient with systemic lupus erythematosus. Intern Med 40: 541-543, 2001.
13. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 21: 1-11, 2007.
14. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 109: 1870-1877, 2007.
15. Hay CR. Acquired hemophilia. Baillieres Clin Haematol 11: 287-303, 1998.
16. Bossi P, Cabane J, Ninet J, et al. Acquired haemophilia due to factor VIII inhibitors in 34 patients. Am J Med 105: 400-408, 1998.
17. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 81: 1513-15120, 1993.
18. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 78: 1463-1467, 1997.
19. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 10: 169-173, 2004.
20. Hedner U. Recombinant factor VIIa as a haemostatic agent. Dis Mon 49: 39-48, 2003.
21. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 32 Suppl 1: 32-38, 2006.
22. Michiels JJ. Acquired haemophilia A in women post-partum: clinical manifestations, diagnosis and treatment. Clin Appl Thromb Hemost 6: 157-161, 2000.